UMN study provides new insight into use of cell replacement therapies to treat muscular dystrophies

MINNEAPOLIS, MN- February 13, 2019 – The University of Minnesota Medical School continues its legacy of advancing cell replacement therapies with a scientific breakthrough that highlights the promise of cell therapies for muscular dystrophy. The research published in Proceedings of the National Academy of Sciences of the United States of America (PNAS) allows authors Tania…

Details

Even as hospitals cut risky antibiotic use in-house, patients often go home with them

IMAGE: A new study of antibiotic prescribing finds that one-third of patients discharged from 48 Michigan hospitals for pneumonia or urinary tract infections received prescription for a fluoroquinolone antibiotic — a… view more  Credit: University of Michigan Even as hospitals try to cut back on prescribing powerful but risky antibiotics for their patients, a new study…

Details

New assay selects patients with lung cancer for treatment with immune checkpoint inhibitors

Philadelphia, PA, February 13, 2019 – Immune checkpoint inhibitors, such as the anti-PD-1 antibody pembrolizumab, have become important tools for managing non-small-cell lung cancer (NSCLC). Assessing the level of programmed death ligand 1 (PD-L1) expressed by a tumor can help clinicians determine how the patient should be treated. A report in The Journal of Molecular…

Details

BFU physicists developed a new method to identify antibiotics-resistant bacteria

IMAGE: This is a holder with samples of mycobacterial strains with different antibiotic resistance. view more  Credit: Andrey Zyubin A team of physicists from Immanuel Kant Baltic State University suggested a method to quickly identify single antibiotic-resistant bacteria cells that are the agents of tuberculosis. The new method helps find the bacteria and evaluate their resistance…

Details